{"id":"https://openalex.org/W2904030871","doi":"https://doi.org/10.3389/fimmu.2018.02905","title":"Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy","display_name":"Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy","publication_year":2018,"publication_date":"2018-12-18","ids":{"openalex":"https://openalex.org/W2904030871","doi":"https://doi.org/10.3389/fimmu.2018.02905","mag":"2904030871","pmid":"https://pubmed.ncbi.nlm.nih.gov/30619269","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6305397"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2018.02905","doi":"https://doi.org/10.3389/fimmu.2018.02905","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.02905","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02905/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02905/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065295889","display_name":"Lorenzo Mortara","orcid":"https://orcid.org/0000-0002-4757-7101","observed_orcids":["https://orcid.org/0000-0002-4757-7101"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Lorenzo Mortara","raw_affiliation_strings":["Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy","institution_ids":["https://openalex.org/I115752224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013448319","display_name":"Enrica Balza","orcid":"https://orcid.org/0000-0002-2597-1810","observed_orcids":["https://orcid.org/0000-0002-2597-1810"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrica Balza","raw_affiliation_strings":["UOC Cell Biology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UOC Cell Biology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023598157","display_name":"Antonino Bruno","orcid":"https://orcid.org/0000-0002-4790-0861","observed_orcids":["https://orcid.org/0000-0002-4790-0861"]},"institutions":[{"id":"https://openalex.org/I4210094922","display_name":"MultiMedica","ror":"https://ror.org/01h8ey223","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094922","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonino Bruno","raw_affiliation_strings":["Vascular Biology and Angiogenesis Laboratory, Scientific and Technologic Park, IRCCS MultiMedica, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vascular Biology and Angiogenesis Laboratory, Scientific and Technologic Park, IRCCS MultiMedica, Milan, Italy","institution_ids":["https://openalex.org/I4210094922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045982942","display_name":"Alessandro Delli Poggi","orcid":"https://orcid.org/0000-0002-1860-430X","observed_orcids":["https://orcid.org/0000-0002-1860-430X","https://orcid.org/0000-0002-9770-4973"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro Poggi","raw_affiliation_strings":["UOSD Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UOSD Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039638460","display_name":"Paola Orecchia","orcid":"https://orcid.org/0000-0003-0556-9784","observed_orcids":["https://orcid.org/0000-0003-0556-9784"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paola Orecchia","raw_affiliation_strings":["UOC Immunology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UOC Immunology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100992559","display_name":"Barbara Carnemolla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Barbara Carnemolla","raw_affiliation_strings":["UOC Immunology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UOC Immunology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5065295889"],"corresponding_institution_ids":["https://openalex.org/I115752224"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":1.3086,"has_fulltext":true,"cited_by_count":141,"citation_normalized_percentile":{"value":0.81380915,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"9","issue":null,"first_page":"2905","last_page":"2905"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.801800012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.801800012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.08009999990463257,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.07800000160932541,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-cytokine-fusion-proteins","display_name":"antibody-cytokine fusion proteins","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9079999923706055},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/t-helper-1-response","display_name":"T helper 1 response","score":0.8220000267028809},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9160000085830688},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.8939999938011169},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9850000143051147},{"id":"https://openalex.org/keywords/il-2-toxicity","display_name":"IL-2 toxicity","score":0.8119999766349792},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.875},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7303770184516907},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.60853111743927},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5787990689277649},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5393078327178955},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5280863642692566},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4937780797481537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47841745615005493},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4642273783683777},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.4312966763973236},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4275503158569336},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4165405035018921},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2880381941795349},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.14321377873420715},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0732705295085907},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019139","descriptor_name":"Tumor Escape","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019139","descriptor_name":"Tumor Escape","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D059248","descriptor_name":"Chemoradiotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.3389/fimmu.2018.02905","doi":"https://doi.org/10.3389/fimmu.2018.02905","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.02905","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02905/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5293916","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6305397","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6305397","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6305397","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:30619269","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30619269","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5d6ef4e006194884ae2862d747b08630","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5d6ef4e006194884ae2862d747b08630","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 9 (2018)","raw_type":"article"},{"id":"pmh:oai:irinsubria.uninsubria.it:11383/2077444","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11383/2077444","pdf_url":null,"source":{"id":"https://openalex.org/S4377196351","display_name":"IrInSubria (University of Insubria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I115752224","host_organization_name":"University of Insubria","host_organization_lineage":["https://openalex.org/I115752224"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2018.02905","doi":"https://doi.org/10.3389/fimmu.2018.02905","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.02905","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02905/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1471011659","display_name":null,"funder_award_id":"GR-2013-02356568","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G2462982473","display_name":null,"funder_award_id":"5xmille 2015","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G2961954102","display_name":null,"funder_award_id":"FFABR 2017","funder_id":"https://openalex.org/F4320321873","funder_display_name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca"},{"id":"https://openalex.org/G5028142142","display_name":null,"funder_award_id":"2017-2019","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G5084998961","display_name":null,"funder_award_id":"grant FFABR 2017","funder_id":"https://openalex.org/F4320321873","funder_display_name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca"},{"id":"https://openalex.org/G532046197","display_name":null,"funder_award_id":"FAR2017","funder_id":"https://openalex.org/F4320321873","funder_display_name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca"},{"id":"https://openalex.org/G857113660","display_name":null,"funder_award_id":"FAR2017","funder_id":"https://openalex.org/F4320323281","funder_display_name":"Universit\u00e0 degli Studi dell'Insubria"}],"funders":[{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"},{"id":"https://openalex.org/F4320321873","display_name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","ror":"https://ror.org/0166hxq48"},{"id":"https://openalex.org/F4320323281","display_name":"Universit\u00e0 degli Studi dell'Insubria","ror":"https://ror.org/00s409261"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2904030871.pdf","grobid_xml":"https://content.openalex.org/works/W2904030871.grobid-xml"},"referenced_works_count":95,"referenced_works":["https://openalex.org/W35202944","https://openalex.org/W269359229","https://openalex.org/W272579771","https://openalex.org/W772502730","https://openalex.org/W1544772950","https://openalex.org/W1556867369","https://openalex.org/W1624861557","https://openalex.org/W1950572133","https://openalex.org/W1972825083","https://openalex.org/W1975865143","https://openalex.org/W1976527118","https://openalex.org/W1990711717","https://openalex.org/W1993543117","https://openalex.org/W1993969840","https://openalex.org/W1994829121","https://openalex.org/W1995200679","https://openalex.org/W1996571930","https://openalex.org/W2004739430","https://openalex.org/W2009420231","https://openalex.org/W2009713492","https://openalex.org/W2024365659","https://openalex.org/W2025309900","https://openalex.org/W2028931972","https://openalex.org/W2034134615","https://openalex.org/W2038432511","https://openalex.org/W2041634248","https://openalex.org/W2043098287","https://openalex.org/W2043944189","https://openalex.org/W2047059447","https://openalex.org/W2048657818","https://openalex.org/W2049345643","https://openalex.org/W2051962533","https://openalex.org/W2061978660","https://openalex.org/W2064229689","https://openalex.org/W2070855360","https://openalex.org/W2073128146","https://openalex.org/W2082418977","https://openalex.org/W2084359787","https://openalex.org/W2086640052","https://openalex.org/W2092941122","https://openalex.org/W2095138364","https://openalex.org/W2096619429","https://openalex.org/W2098052315","https://openalex.org/W2099050377","https://openalex.org/W2099578238","https://openalex.org/W2101337372","https://openalex.org/W2104057153","https://openalex.org/W2107746773","https://openalex.org/W2108473659","https://openalex.org/W2108555563","https://openalex.org/W2109163566","https://openalex.org/W2109896022","https://openalex.org/W2110489920","https://openalex.org/W2111601282","https://openalex.org/W2114683657","https://openalex.org/W2117692326","https://openalex.org/W2120813964","https://openalex.org/W2121146521","https://openalex.org/W2123798417","https://openalex.org/W2139837928","https://openalex.org/W2148640623","https://openalex.org/W2149859333","https://openalex.org/W2153494864","https://openalex.org/W2153875966","https://openalex.org/W2156222101","https://openalex.org/W2161798205","https://openalex.org/W2162620875","https://openalex.org/W2170379319","https://openalex.org/W2176846278","https://openalex.org/W2269860277","https://openalex.org/W2281137630","https://openalex.org/W2326245275","https://openalex.org/W2346039915","https://openalex.org/W2439226702","https://openalex.org/W2517693655","https://openalex.org/W2522468074","https://openalex.org/W2558827380","https://openalex.org/W2572762406","https://openalex.org/W2579745428","https://openalex.org/W2587783849","https://openalex.org/W2588457489","https://openalex.org/W2727010309","https://openalex.org/W2776429196","https://openalex.org/W2783973128","https://openalex.org/W2788587230","https://openalex.org/W2788938747","https://openalex.org/W2793173889","https://openalex.org/W2794097834","https://openalex.org/W2797225625","https://openalex.org/W2802217282","https://openalex.org/W2830145191","https://openalex.org/W2887245816","https://openalex.org/W4254494911","https://openalex.org/W6636781092","https://openalex.org/W6675202685"],"related_works":["https://openalex.org/W4406326998","https://openalex.org/W1570123945","https://openalex.org/W4407866414","https://openalex.org/W4313406934","https://openalex.org/W2319871595","https://openalex.org/W2049961431","https://openalex.org/W4385686413","https://openalex.org/W7118849725","https://openalex.org/W1987155779","https://openalex.org/W7135741567"],"abstract_inverted_index":{"Antibody-cytokine":[0],"fusion":[1],"proteins":[2],"(immunocytokines)":[3],"exert":[4],"a":[5,63,67,122,203],"potent":[6],"anti-tumor":[7,73,215],"effect":[8],"by":[9,29,77,99],"specific":[10],"antibodies":[11],"and":[12,44,55,82,134,161,187,195,213,225],"delivering":[13],"cytokines":[14],"to":[15,23,94,227],"the":[16,24,40,78,112,141,145,197,206],"immunesuppressive":[17],"tumor":[18,25,96],"microenvironment":[19],"(TME).":[20],"Once":[21],"bound":[22],"target,":[26],"immunocytokines":[27,89,119,176,210],"composed":[28],"antibody":[30,100],"or":[31],"single":[32],"chain":[33],"Fv":[34],"conjugated":[35,120],"with":[36,118,121,180,202],"interleukin-2,":[37],"can":[38,114,139],"promote":[39],"in":[41,157,164,178],"situ":[42],"recruitment":[43,61],"activation":[45],"of":[46,111,125,144,148,151,189,208],"effector":[47],"immune":[48,74,190,216],"cells,":[49],"such":[50],"as":[51,155,219,221],"natural":[52],"killer":[53],"(NK)":[54],"cytotoxic":[56],"T":[57,69,130],"lymphocytes":[58],"(CTL).":[59],"This":[60],"induces":[62],"TME":[64,113],"switch":[65],"towards":[66],"classical":[68],"helper":[70],"1":[71],"(TH1)":[72],"response,":[75],"supported":[76],"crosstalk":[79],"between":[80],"NK":[81],"dendritic":[83],"cells":[84,224],"(DC).":[85],"Furthermore,":[86],"some":[87],"IL-2":[88,126,136,175,209],"have":[90,171],"been":[91,172],"largely":[92],"shown":[93],"trigger":[95],"cell":[97,132,217],"killing":[98],"dependent":[101],"cellular":[102],"cytotoxicity":[103],"(ADCC),":[104],"through":[105],"Fc\u03b3":[106],"receptors":[107],"engagement.":[108],"The":[109],"modulation":[110],"be":[115],"also":[116],"achieved":[117],"mutated":[123],"form":[124],"that":[127],"impairs":[128],"regulatory":[129],"(Treg)":[131],"proliferation":[133],"activity.":[135],"immunocytokine":[137],"administration":[138,147],"overcome":[140],"severe":[142,230],"toxicities":[143],"systemic":[146],"high":[149],"doses":[150],"soluble":[152],"unconjugated":[153],"IL-2,":[154],"demonstrated":[156],"preclinical":[158],"animal":[159],"models":[160],"more":[162],"recently":[163],"phase":[165],"I/II":[166],"clinical":[167],"trials.":[168],"Promising":[169],"results":[170],"reported":[173,200],"using":[174],"delivered":[177],"combination":[179],"other":[181],"immunocytokines,":[182],"chemo-,":[183],"radio-,":[184],"anti-angiogenic":[185],"therapies,":[186],"blockade":[188],"checkpoints.":[191],"Here,":[192],"we":[193],"summarize":[194],"discuss":[196],"most":[198],"relevant":[199],"studies":[201],"focus":[204],"on":[205,211],"effects":[207],"innate":[212],"adaptive":[214],"responses":[218],"well":[220],"immunosuppressive":[222],"Treg":[223],"approaches":[226],"circumvent":[228],"its":[229],"toxic":[231],"side":[232],"effects.":[233]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":23},{"year":2022,"cited_by_count":25},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":9},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-12-22T00:00:00"}